TY  - JOUR 
T1  - Effects of pemafibrate (a selective PPAR-α agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLD
JO  - Clinics
A1  - Kato, Kanako
A1  - Jojima, Teruo
A1  - Tanuma, Dai
A1  - Suda, Kanako
A1  - Sakurai, Shintaro
A1  - Iijima, Toshie
A1  - Tomaru, Takuya
A1  - Usui, Isao
A1  - Aso, Yoshimasa
SN  - 1807-5932
UL  - 10.1016/j.clinsp.2025.100839
VL  - 80 
Y1  - 2025
PB  - Brasil 
ER  -